Loncar Cancer Immunotherapy ETF (CNCR)
NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Overall Portfolio Composition (%)
Stocks99.94%
Bonds0.00%
Sector Weightings (%)
Sector(s)CNCR
Basic Materials0.00%
Consumer Cyclical0.00%
Financial Services0.00%
Real Estate0.00%
Consumer Defensive0.00%
Healthcare100.00%
Utilities0.00%
Communication Services0.00%
Energy0.00%
Industrials0.00%
Technology0.00%
Equity Holdings
AverageCNCR
Price/Earnings0
Price/Book0.39
Price/Sales0.12
Price/Cashflow0
Median Market CapN/A
3 Year Earnings GrowthN/A
Bond Ratings
Sector(s)CNCR
US Government0.00%
AAAN/A
AAN/A
AN/A
BBBN/A
BBN/A
BN/A
Below BN/A
OthersN/A
Top 10 Holdings (27.17% of Total Assets)
Get Quotes for Top Holdings| Name | Symbol | % Assets |
|---|---|---|
| Janux Therapeutics Inc Ordinary Shares | JANX | 3.43% |
| Fate Therapeutics Inc | FATE | 3.00% |
| Y-mAbs Therapeutics Inc | YMAB | 2.93% |
| Macrogenics Inc | MGNX | 2.84% |
| Mersana Therapeutics Inc | MRSN | 2.84% |
| ImmunityBio Inc Ordinary Shares | IBRX | 2.69% |
| Iovance Biotherapeutics Inc | IOVA | 2.53% |
| Nuvation Bio Inc Ordinary Shares - Class A | NUVB | 2.52% |
| Revolution Medicines Inc Ordinary Shares | RVMD | 2.33% |
| MorphoSys AG ADR | MOR | 2.03% |
© 2024 Yahoo. All rights reserved.